UBS Group’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.83M Sell
128,477
-9,002
-7% -$495K ﹤0.01% 3715
2026
Q1
$6.13M Buy
137,479
+27,385
+25% +$1.08M ﹤0.01% 3845
2025
Q4
$4.22M Sell
110,094
-223,906
-67% -$7.62M ﹤0.01% 4192
2025
Q3
$11.2M Buy
334,000
+133,206
+66% +$4.81M ﹤0.01% 3165
2025
Q2
$7.93M Buy
200,794
+151,995
+311% +$6.33M ﹤0.01% 3350
2025
Q1
$1.72M Buy
48,799
+1,243
+3% +$43.3K ﹤0.01% 4831
2024
Q4
$1.48M Buy
47,556
+32,620
+218% +$913K ﹤0.01% 4995
2024
Q3
$353K Sell
14,936
-3,119
-17% -$69.6K ﹤0.01% 5471
2024
Q2
$361K Buy
+18,055
New +$355K ﹤0.01% 5241

Other funds holding MRX

UBS Group's MRX Position: Q2 2026 in Review

UBS Group reduced its Marex Group Limited Ordinary Shares (MRX) stake by 6.5% in Q2 2026, selling an estimated $495K and leaving 128,477 shares worth $7.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3715.

UBS Group first reported a position in MRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.2M in Q3 2025. 221 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • UBS Group held 128,477 shares of Marex Group Limited Ordinary Shares worth $7.83M as of Q2 2026.
  • UBS Group sold 9,002 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $495K.
  • Marex Group Limited Ordinary Shares made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3715 holding.
  • UBS Group first reported a position in Marex Group Limited Ordinary Shares in Q2 2024 and has held it in 9 quarters since.
  • UBS Group's Marex Group Limited Ordinary Shares position peaked at $11.2M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.